Related references
Note: Only part of the references are listed.Rasistion- and obasky-associated metabolic diseases
M. A. Lazar
HORMONE AND METABOLIC RESEARCH (2007)
Mechanisms of obesity-associated insulin resistance: many choices on the menu
Mohammed Qatanani et al.
GENES & DEVELOPMENT (2007)
Thiazolidinediones in patients with type 2 diabetes mellitus and heart failure
Mark C. Granberry et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2007)
A growth hormone-releasing peptide promotes mitochondrial biogenesis and a fat burning-like phenotype through scavenger receptor CD36 in white adipocytes
Amelie Rodrigue-Way et al.
ENDOCRINOLOGY (2007)
The hormonal response of estrogen receptor β is decreased by the phosphatidylinositol 3-kinase/Akt pathway via a phosphorylation-dependent release of CREB-binding protein
Melanie Sanchez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
CD36: Implications in cardiovascular disease
Maria Febbraio et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
A growth hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor up-regulates sterol transporters and cholesterol efflux in macrophages through a peroxisome proliferator-activated receptor γ- dependent pathway
Roberta Avallone et al.
MOLECULAR ENDOCRINOLOGY (2006)
Scavenger receptors in atherosclerosis: Beyond lipid uptake
Kathryn J. Moore et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
PPARγ and human metabolic disease
RK Semple et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
PPARδ:: a dagger in the heart of the metabolic syndrome
GD Barish et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Sorting out the roles of PPARα in energy metabolism and vascular horneostasis
P Lefebvre et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
PGC-1 coactivators: inducible regulators of energy metabolism in health and disease
BN Finck et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Cardiac and peripheral actions of growth honnone and its releasing peptides: Relevance for the treatment of cardiomyopathies
S Marleau et al.
CARDIOVASCULAR RESEARCH (2006)
Mechanisms of disease: Retinoid X receptor heterodimers in the metabolic syndrome
AI Shulman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Thiazolidinediones expand body fluid volume through PPARγ stimulation of ENaC-mediated renal salt absorption
YF Guan et al.
NATURE MEDICINE (2005)
Collecting duct-specific deletion of peroxisome proliferator-activated receptor γ blocks thiazolidinedione-induced fluid retention
H Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Hyperleptinemia - Protecting the heart from lipid overload
RH Unger
HYPERTENSION (2005)
Metabolic control through the PGC-1 family of transcription coactivators
JD Lin et al.
CELL METABOLISM (2005)
Insulin resistance in type 2 diabetes - Role of the adipokines
P Arner
CURRENT MOLECULAR MEDICINE (2005)
Transcriptional coactivator PGC-1α controls the energy state and contractile function of cardiac muscle
Z Arany et al.
CELL METABOLISM (2005)
Kinase signaling cascades that modulate peroxisome proliferator-activated receptors
L Gelman et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
Drug therapy: Thiazolidinediones
H Yki-Jarvinen
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Identification of the growth hormone-releasing peptide binding site in CD36: a photoaffinity cross-linking study
A Demers et al.
BIOCHEMICAL JOURNAL (2004)
Genotype in human CD36 deficiency and diabetes mellitus
M Furuhashi et al.
DIABETIC MEDICINE (2004)
Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARα, β/δ, and β
AC Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor
NM Thompson et al.
ENDOCRINOLOGY (2004)
Peroxisome proliferator-activated receptor γ in diabetes and metabolism
SM Rangwala et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Adipose tissue as an endocrine organ
EE Kershaw et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Biological control through regulated transcriptional coactivators
BM Spiegelman et al.
CELL (2004)
Nuclear receptors in macrophage biology: At the crossroads of lipid metabolism and inflammation
A Castrillo et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY (2004)
Inhibition of adipogenesis by ghrelin
WZ Zhang et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Defects in adaptive energy metabolism with CNS-Linked hyperactivity in PGC-1α null mice
JD Lin et al.
CELL (2004)
CD36, oxidized LDL and PPARγ:: pathological interactions in macrophages and atherosclerosis
AC Nicholson et al.
VASCULAR PHARMACOLOGY (2004)
Adipose-specific peroxisome proliferator-activated receptor γ knockout causes insulin resistance in fat and liver but not in muscle
WM He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Muscle-specific Pparg deletion causes insulin resistance
AL Hevener et al.
NATURE MEDICINE (2003)
Transcriptional repression of atherogenic inflammation:: Modulation by PPARδ
CH Lee et al.
SCIENCE (2003)
Liver peroxisome proliferator-activated receptor γ contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass
O Gavrilova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Muscle-specific PPARγ-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones
AW Norris et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Bioenergetic analysis of peroxisome proliferator-activated receptor γ coactivators 1α and 1β (PGC-1α and PGC-1β) in muscle cells
J St-Pierre et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Ghrelin plays a minor role in the physiological control of cardiac function in the rat
A Torsello et al.
ENDOCRINOLOGY (2003)
Liver-specific disruption of PPARγ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes
K Matsusue et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages
VV Kunjathoor et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The macrophage foam cell as a target for therapeutic intervention
AC Li et al.
NATURE MEDICINE (2002)
Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36
EA Podrez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions
EA Podrez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects
JG Yu et al.
DIABETES (2002)
Regulation of peroxisome proliferator-activated receptor-γ-mediated gene expression -: A new mechanism of action for high density lipoprotein
JH Han et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells
N Shojima et al.
DIABETES (2002)
CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart
V Bodart et al.
CIRCULATION RESEARCH (2002)
Autoregulation of the human liver X receptor α promoter
BA Laffitte et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Peroxisome proliferator-activated receptor-α regulates lipid homeostasis, but is not associated with obesity -: Studies with congenic mouse lines
TE Akiyama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein
N Maeda et al.
DIABETES (2001)
Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance
CJ de Souza et al.
DIABETES (2001)
Diabetic KKAy mice exhibit increased hepatic PPARγ1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones
M Bedoucha et al.
JOURNAL OF HEPATOLOGY (2001)
Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor
M Kojima et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2001)
Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor γ activation has coordinate effects on gene expression in multiple insulin-sensitive tissues
JM Way et al.
ENDOCRINOLOGY (2001)
The hormone resistin links obesity to diabetes
CM Steppan et al.
NATURE (2001)
A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis
A Chawla et al.
MOLECULAR CELL (2001)
Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones
L Chao et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Peroxisome proliferator-activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis
JJ Lehman et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Down-regulation by troglitazone of hepatic tumor necrosis factor-α and interleukin-6 mRNA expression in a murine model of non-insulin-dependent diabetes
S Sigrist et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
M Febbraio et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
